Maximum quantity allowed is 999
CAS RN: 250285-32-6 | 产品编码: R0316
1,3-Bis(2,6-diisopropylphenyl)imidazolium Chloride (HPMC encapsulated)

* 无具体发货日期的情况,如:显示“8个工作日后发货”,将在您订购日起的8个工作日后发货。
* 我们将以最优方式从上海/天津两大仓库发货。国内库存不足,需两周左右向日本总部调货。
* 对于可分装产品,11:30前的订单,当天发货;11:30后的订单,隔天发货。
* 如需大包装,请点击“大包装询价”按钮(对于某些产品我们无法提供大包装)。
* TCI会经常复审储藏条件以对其进行优化,请以在线目录为准,敬请留意。
* 更多信息,请联系营业部:021-67121386 / Sales-CN@TCIchemicals.com 。任何货期、规格或包装方面的需求,请联系我们 。
补充产品信息:
Contents (per one capsule)
- IPr·HCl ca. 0.125 mmol
Uses of Reagent
- Applicable to palladium-catalyzed reactions due to a ligand encapsulated in HPMC capsules
Soluble Solvents
- Water, DMSO, DMF, 1,4-Dioxane (50°C), THF/Water mixture, 1,2-Dimethoxyethane/Water mixture
Related Product
- D3611 1,3-Bis(2,6-diisopropylphenyl)imidazolium Chloride
产品编码 | R0316 |
分子式/分子量 | C__2__7H__3__7ClN__2 = 425.06 |
外观与形状(20°C) | 固体 |
储存温度 ![]() |
室温 (15°C以下阴凉干燥处) |
储存在惰性气体下 | 存放于惰性气体之中 |
应避免的情况 | 湿气 (吸湿) |
CAS RN | 250285-32-6 |
Appearance | White to Almost white capsule |
Functionality test (conversion ratio) | min.80.0 % |
象形图 |
![]() |
信号词 | 警告 |
危险性说明 | H315 : 造成皮肤刺激。 H319 : 造成严重眼刺激。 |
防范说明 | P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/戴防护眼罩/戴防护面具。 P302 + P352 : 如皮肤沾染:用水充分清洗。 P337 + P313 : 如仍觉眼刺激:求医/就诊。 P305 + P351 + P338 : 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P362+P364 : 脱掉沾污的衣服,清洗后方可重新使用。 P332 + P313 : 如发生皮肤刺激:求医/就诊。 |
新化学物质备案回执号 | B1A232214940 |
监管条件代码(*) |
-
Used Chemicals
-
Procedure
-
Pd2(dba)3 (HPMC encapsulated) (one capsule) and IPr·HCl (HPMC encapsulated) (one capsule) were added to a solution of 2-acetamido-5-bromo-4-methylpyridine (286mg, 1.25 mmol), cesium carbonate (448 mg, 1.38 mmol, 1.1 eq.) and phenylboronic acid (229 mg, 1.88 mmol, 1.5 eq.) in THF/water (10:1, 7.1 mL) at room temperature and the reaction mixture was stirred at 100 °C for 2 hours. The solution was then diluted with ethyl acetate (3.2 mL) and sat. Na2SO4 aq. (3.2mL), and filtered through Celite pad. The filtrate was separated and the organic layer was washed with water (15 mL) and brine (15 mL), dried over sodium sulfate and concentrated under reduced pressure. The crude product was purified by silica gel chromatography (ethyl acetate: hexane = 1:2 - 1:1) to afford 2-acetamido-4-methyl-5-phenylpyridine (294 mg, 96% yield) as a white solid.
-
Experimenter’s Comments
-
The reaction mixture was monitored by GC.
The material of the capsule is water-soluble HPMC (hydroxypropyl methylcellulose).
The shape of the capsule is like the image below and Pd2(dba)3 (ca. 60 μmol) and IPr·HCl (ca. 125 μmol) are encapsulated in each capsule, respectively.
The capsule disintegrates as shown in the image below when stirred in the solvent for about 15 minutes, releasing its content.
-
Analytical Data
-
2-Acetamido-4-methyl-5-phenylpyridine
1H NMR (400 MHz, CDCl3); δ 9.24-9.06 (brs, 1H), 8.16 (s, 1H), 8.10 (s, 1H), 7.46-7.36 (m, 3H), 7.30-7.29 (m, 2H), 2.32 (s, 3H), 2.21 (s, 3H).
-
Lead Reference
-
- Reagent and Catalyst Capsules: A Chemical Delivery System for Reaction Screening and Parallel Synthesis
-
Other References
-
- HPMC: A Biomass-Based Semisynthetic Sustainable Additive Enabling Clean and Fast Chemistry in Water
化学品安全说明书(SDS)
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
示例 CoA
目前没有该产品的 CoA 示例。
分析图谱
很抱歉,您搜索的分析图谱无法提供。